|1.||Kerin, Michael J: 4 articles (01/2014 - 01/2009)|
|2.||Miller, Nicola: 3 articles (01/2014 - 01/2009)|
|3.||Lowery, Aoife J: 3 articles (06/2012 - 01/2009)|
|4.||Ooi, Akishi: 3 articles (07/2002 - 01/2002)|
|5.||Tsuda, H: 3 articles (01/2001 - 01/2000)|
|6.||Fukutomi, T: 3 articles (01/2001 - 01/2000)|
|7.||Nanni, Patrizia: 2 articles (01/2014 - 11/2010)|
|8.||Cavallo, Federica: 2 articles (01/2014 - 06/2006)|
|9.||Ball, Graham: 2 articles (01/2014 - 01/2009)|
|10.||Errihani, Hassan: 2 articles (01/2014 - 01/2011)|
03/01/2008 - "The expression of the HER2/neu receptor is related to a reduction of the disease-free interval and global survival in patients with infiltrating ductal breast carcinoma locally advanced, confirming, in this work, to be a good prognostic factor."
11/01/2010 - "The prevention of mammary carcinoma by immunological strategies targeting the HER-2/neu receptor has proved to be effective in preclinical models. "
06/01/2000 - "Consequently, the purpose of this study was to assay the c-erbB-2 protein in the saliva and serum of women with and without carcinoma of the breast and to determine whether the protein possesses any diagnostic value. "
01/01/1994 - "c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study."
01/01/1993 - "[Immunohistochemical study of the c-erbB-2 protein in human gastric carcinoma]."
|2.||Breast Neoplasms (Breast Cancer)
06/01/2013 - "In this study, we found that reduced TAP expression was significantly correlated with Her2/neu receptor expression, breast cancer stage and nodal stage in paired normal and cancerous breast tissue samples from 93 patients using real-time PCR analysis. "
01/01/2012 - "The objective of this study was to compare the salivary protein profiles from individuals diagnosed with breast cancer that were either HER2/neu receptor positive or negative. "
02/15/2011 - "The results of the study showed that the lead drug tested significantly inhibited the growth of HER2/neu-positive breast cancer cells in vitro and in vivo by enhanced apoptosis and inhibition of HER2/neu receptor signaling with suppression of Akt phosphorylation. "
09/01/2000 - "The present study was initiated to determine the prognostic significance of c-erbB-2 protein overexpression in early onset breast cancer. "
11/01/1996 - "In addition, this study demonstrated that the c-erbB-2 protein over-expression was an effective independent prognostic indicator in patients with breast cancer."
08/01/1992 - "Patients with tumors containing high amounts of the c-erbB-2 protein had a significantly shorter (P less than 0.001) disease-free interval and overall survival rate than did patients with low amounts. "
08/01/2011 - "The aim of the study was to evaluate the role of c-erbB-2 protein expression in various groups of astrocytic tumors. "
09/15/2005 - "In the present study, we demonstrate that a physical association between the extracellular domain of human HER2/neu receptor (ECDHER2) plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) was required to elicit the most effective anti-tumor immune response against a syngeneic tumor expressing rat HER2/neu. "
01/01/1998 - "Immunohistochemical studies of the tumor revealed overexpression of p53 protein, but not that of c-erbB-2 protein. "
07/01/1997 - "In the present study, we evaluated the expression of EGFR and c-erbB-2 protein in 33 astrocytic tumors with immunohistochemistry. "
06/14/1995 - "The ErbB-2 receptor (ErbB-2R) is overproduced in a high percentage of adenocarcinomas arising in the breast, ovary, lung and stomach, when compared to normal cells. "
07/01/1994 - "p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. "
01/01/1994 - "Out of 40 adenocarcinomas, only 2 samples showed weak immunoreaction, while 38 samples were moderately or strongly positive for c-erbB-2 protein. "
01/01/1994 - "High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters."
01/01/1994 - "c-erbB-2 protein expression could be an important prognostic indicator in Barrett's adenocarcinoma."
|5.||Colorectal Neoplasms (Colorectal Cancer)
11/01/2000 - "The present study was undertaken to examine the significance of c-erbB-2 protein expression as a prognostic factor in colorectal cancer. "
11/01/1998 - "Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival."
02/12/2002 - "In terms of prognosis, no association was seen between either c-erbB-2 protein expression or the presence of the Val allele and patient survival (P>0.05 in each case), suggesting that c-erbB-2 is not a prognostic marker in colorectal cancer."
01/01/2002 - "Overexpression of the c-erbB-2 protein (also called HER-2/neu) is observed in a variety of malignancies including colorectal cancer (CRC). "
01/01/2002 - "Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas."
|1.||Epidermal Growth Factor Receptor (EGF Receptor)
|4.||DNA (Deoxyribonucleic Acid)
|5.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|8.||Progesterone Receptors (Progesterone Receptor)
|1.||Drug Therapy (Chemotherapy)